This is the authors' abstract. We don't add key points for this paper.
Background Adjuvant chemotherapy reduces cancer recurrence and improves survival in eligible patients. Barriers to care may contribute to inequities in outcomes. We examined the association between neighborhood socioeconomic status (SES) and ethnic diversity with receipt of adjuvant chemotherapy in stage III colon cancer patients. Methods A population-based retrospective cohort study was conducted on adults undergoing surgery for stage III colon cancer (2007–2020). SES and ethnic diversity, defined by quintiles from census data, were the primary exposures. Outcomes were receipt of medical oncology consultation and adjuvant chemotherapy within 3 months post-surgery. Logistic regression measured the association between each exposure and outcomes, adjusting for confounders. A sub-group analysis was performed on patients who received a medical oncology consultation. Results Of 14,511 patients, 10,973 (76.5%) received medical oncology consultation and 8,814 (61.4%) adjuvant chemotherapy. SES and ethnic diversity were not associated with medical oncology consultation after adjusting for age, sex, surgical approach, and comorbidities. However, the lowest SES quintile and highest ethnic diversity quintile were associated with lower odds of adjuvant chemotherapy (OR 0.70; 95% CI 0.62-0.80 and OR 0.72; 95% CI 0.64-0.82, respectively). These associations persisted at 6 months post-surgery. Among patients who had a medical oncology consultation, both the lowest SES and highest ethnic diversity quintiles were associated with lower odds of adjuvant chemotherapy. Conclusion Lower SES and higher ethnic diversity were independently associated with lower odds of adjuvant chemotherapy but not medical oncology consultation, highlighting disparities in outcomes for marginalized patients within a universal healthcare system. SYNOPSIS We examined the association between neighborhood socioeconomic status (SES) and ethnic diversity with receipt of adjuvant chemotherapy in stage III colon cancer patients in Ontario. Those from the lowest SES or most diverse neighborhoods had 30% and 28% lower odds of receiving chemotherapy, highlighting disparities within a universal healthcare system.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Bondzi-Simpson et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: